ROXANNE BROMFIELD: Open Payments
NPI 1598534406 · OAKLAND PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$816 in 48 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $2,042 · 2025 $816
Food & beverage: $816
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 23 | $337 |
| ViiV Healthcare Company | 11 | $209 |
| Novo Nordisk Inc | 3 | $75 |
| Amgen Inc. | 3 | $48 |
| ABBVIE INC. | 2 | $33 |
| Hologic Sales and Service, LLC | 1 | $30 |
| EMD Serono, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: RUKOBIA, CABENUVA, Ozempic, Biktarvy, QULIPTA, OTEZLA, DOVATO, APTIMA.
Industry payments across FL — which companies pay providers there.
